HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Mikulska Selected Research
M Mikulska Research Topics
Disease
8
Infections
08/2021 - 12/2004
4
Aspergillosis
01/2019 - 09/2009
4
Neutropenia
07/2018 - 09/2009
4
Sepsis (Septicemia)
06/2018 - 04/2009
3
Neoplasms (Cancer)
01/2020 - 06/2012
3
Opportunistic Infections (Opportunistic Infection)
12/2018 - 04/2009
3
Communicable Diseases (Infectious Diseases)
06/2018 - 06/2012
3
Hepatitis B
06/2018 - 10/2014
2
Relapsing-Remitting Multiple Sclerosis
10/2020 - 11/2018
2
Multiple Sclerosis
10/2020 - 11/2018
2
Mycoses (Diseases, Fungus)
06/2012 - 04/2009
1
COVID-19
07/2020
1
Hematologic Diseases (Blood Diseases)
01/2020
1
Mucormycosis
01/2019
1
Hodgkin Disease (Hodgkin's Disease)
12/2018
1
Visceral Leishmaniasis (Kala Azar)
12/2018
1
Exanthema (Rash)
11/2018
1
Serum Sickness
11/2018
1
Arthralgia (Joint Pain)
11/2018
1
Fever (Fevers)
11/2018
1
Varicella Zoster Virus Infection
06/2018
1
Lymphopenia (Lymphocytopenia)
06/2018
1
Respiratory Tract Infections (Respiratory Tract Infection)
06/2018
1
Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
06/2018
1
Febrile Neutropenia
01/2018
1
Hepatitis
12/2017
1
Latent Infection
12/2017
1
Lymphoma (Lymphomas)
12/2017
1
Fever of Unknown Origin
03/2015
1
Invasive Candidiasis
06/2012
1
Cryptococcosis
06/2012
1
Leukemia
06/2012
1
Candidemia
03/2011
1
Mucositis
12/2010
1
Bacteremia
12/2010
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2009
1
Unconsciousness (Loss of Consciousness)
04/2009
1
Fungemia
04/2009
Drug/Important Bio-Agent (IBA)
4
Alemtuzumab (Campath)
FDA Link
10/2020 - 04/2009
3
Anti-Bacterial Agents (Antibiotics)
IBA
08/2021 - 02/2015
3
Antiviral Agents (Antivirals)
IBA
07/2020 - 12/2017
3
Hepatitis B Surface Antigens (HBsAg)
FDA Link
06/2018 - 10/2014
2
Tazobactam Drug Combination Piperacillin (Zosyn)
FDA Link
Generic
01/2020 - 07/2012
2
Fluoroquinolones
IBA
01/2020 - 07/2018
2
Monoclonal Antibodies
IBA
11/2018 - 06/2018
2
Surface Antigens (Surface Antigen)
IBA
06/2018 - 06/2018
2
galactomannan
IBA
07/2012 - 06/2012
1
Azoles
IBA
01/2020
1
Carbapenems (Carbapenem Antibiotics)
IBA
01/2020
1
isavuconazole
IBA
01/2019
1
Triazoles
IBA
01/2019
1
Natalizumab (Tysabri)
FDA Link
11/2018
1
lucatumumab
IBA
06/2018
1
blinatumomab
IBA
06/2018
1
dacetuzumab
IBA
06/2018
1
elotuzumab
IBA
06/2018
1
mogamulizumab
IBA
06/2018
1
daratumumab
IBA
06/2018
1
inebilizumab
IBA
06/2018
1
Brentuximab Vedotin
IBA
06/2018
1
Immunoglobulin G (IgG)
IBA
06/2018
1
Proteins (Proteins, Gene)
FDA Link
12/2017
1
DNA (Deoxyribonucleic Acid)
IBA
12/2017
1
Daptomycin
FDA Link
02/2015
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
02/2014
1
Glucans
IBA
06/2012
1
Biomarkers (Surrogate Marker)
IBA
06/2012
1
Biological Products
IBA
06/2012
1
Mannans
IBA
06/2012
1
Sodium Glutamate (Accent)
IBA
06/2012
1
polysaccharide-K
IBA
03/2011
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
12/2010
1
Vancomycin
FDA Link
Generic
12/2010
1
Steroids
IBA
09/2009
1
liposomal amphotericin B
FDA Link
04/2009
1
RNA (Ribonucleic Acid)
IBA
12/2004
Therapy/Procedure
10
Therapeutics
07/2020 - 04/2009
5
Stem Cell Transplantation
10/2020 - 09/2009
2
Drug Therapy (Chemotherapy)
12/2018 - 12/2017
2
Catheters
06/2018 - 02/2015
2
Biological Therapy
06/2018 - 06/2018
1
Debridement
08/2021
1
Urinary Catheters
01/2020
1
Cell Transplantation
12/2018
1
Intravenous Infusions
06/2018